GGrantIndex
← Leaderboards

Charles Joseph Gomer

University Of California Irvine

$5,568,369
Attributed
$5,568,369
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $787.8K · FY200511
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$5,568,369 · 4

By mechanism

R01$5,287,498 · 2
R21$256,237 · 1
P41$24,634 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Photosensitizing Agents

Research focus

Photosensitizing AgentsAngiogenesis InhibitorsVascular Endothelial Growth FactorsApoptosisMcf7 CellNeoplasm /Cancer Photoradiation TherapyProteinsResponseRecurrenceTherapeutic EffectivenessNonhuman Therapy EvaluationNormal Tissue MorphologyPhotochemotherapyMediatingProceduresProgramsImmunocytochemistryInhibitor/AntagonistAffectModalityEffectivenessEnzyme ActivityIn VivoPhototoxicity

Grant awards (24)

Photodynamic Therapy Affects on the Tumor Microenvironment$344,599
R01 · FY2011 · CA · contact PI
Photodynamic Therapy Affects on the Tumor Microenvironment$347,975
R01 · FY2010 · CA · contact PI
Photodynamic Therapy Affects on the Tumor Microenvironment$344,241
R01 · FY2009 · CA · contact PI
Photodynamic Therapy Affects on the Tumor Microenvironment$189,054
R01 · FY2009 · CA · contact PI
Photodynamic Therapy Affects on the Tumor Microenvironment$336,685
R01 · FY2008 · CA · contact PI
Photodynamic Therapy Affects on the Tumor Microenvironment$333,347
R01 · FY2007 · CA · contact PI
Enhancing Photodynamic Therapy with COX-2 Inhibition$313,923
R01 · FY2007 · CA · contact PI
Enhancing Photodynamic Therapy for Treating Kaposi's Sarcoma$140,489
R21 · FY2007 · CA · contact PI
Enhancing Photodynamic Therapy with COX-2 Inhibition$323,299
R01 · FY2006 · CA · contact PI
Enhancing Photodynamic Therapy for Treating Kaposi's Sarcoma$115,748
R21 · FY2006 · CA · contact PI
Enhancing Photodynamic Therapy with COX-2 Inhibition$331,080
R01 · FY2005 · CA
Enhancing Photodynamic Therapy with COX-2 Inhibition$331,080
R01 · FY2004 · CA
Photodynamic Therapy Plus Antiangiogenic Therapy$310,420
R01 · FY2004 · CA
Enhancing Photodynamic Therapy with COX-2 Inhibition$50,577
R01 · FY2004 · CA
Enhancing Photodynamic Therapy with COX-2 Inhibition$331,080
R01 · FY2003 · CA
Photodynamic Therapy Plus Antiangiogenic Therapy$310,420
R01 · FY2003 · CA
Photodynamic Therapy Plus Antiangiogenic Therapy$99,961
R01 · FY2003 · CA
Enhancing Photodynamic Therapy with COX-2 Inhibition$43,822
R01 · FY2003 · CA
Photodynamic Therapy Plus Antiangiogenic Therapy$310,420
R01 · FY2002 · CA
PHOTOSENSITIZER LOCALIZATION IN PDT RESISTANT &PDT SENSITIVE CELLS$0
P41 · FY2002 · RR
Photodynamic Therapy Plus Antiangiogenic Therapy$310,420
R01 · FY2001 · CA
PHOTOSENSITIZER LOCALIZATION IN PDT RESISTANT &PDT SENSITIVE CELLS$0
P41 · FY2001 · RR
MOLECULAR DETERMINANTS OF PHOTODYNAMIC THERAPY$325,095
R01 · FY2000 · CA
PHOTOSENSITIZER LOCALIZATION IN PDT RESISTANT &PDT SENSITIVE CELLS$24,634
P41 · FY2000 · RR